New Pivot Point
On March 29, $Gilead Sciences(GILD.US$ and $Xilio Therapeutics(XLO.US$ ' announced that they have reached an exclusive license agreement totaling more than 600 million US dollars.
Here's a look at some technical analysis:
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Operations Specialist, Shellback Sailor, Human Calculator, Long-time Investor, Stock Market Secrets
220Followers
41Following
1218Visitors
Follow
Pumpui : Just buy and hold. The gilead news is worth it. Plus any breakthru in cancer treatment for biohealth will be huge. I am holding
RockaphobicOP Pumpui: Absolutely! I can't help but feel a bit of confidence. With such promising news, coupled with the fact that Vanguard is one of the 52 institutional shareholders. Sign me up!
GL!